PEMPHIGUS 2005-PROGRESS AND FUTURE DIRECTIONS
PEMPHIGUS 2005-PROGRESS AND FUTURE DIRECTIONS
批准号:
6941033
负责人:
JEAN-CLAUDE BYSTRYN
金额:
$4.0万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-05-20 至 2005-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Pemphigus is a serious blistering disease of the skin. It is a model auto-antibody mediated disease, caused by auto-antibodies against the keratinocyte adhesion molecules desmoglein 1 and 3. Rapid advances are being made understanding the pathogenesis of pemphigus and developing novel approaches to it. The first national conference on this disease was held on the NIH campus 4 years ago and was very successful. We now propose a follow-up conference-- "Pemphigus 2005 - Progress and Future Directions". It will bring together basic scientists and clinical investigators working on the mechanisms of, and novel therapeutic approaches to, human auto-antibody mediated diseases in general and pemphigus specifically. Up-to-date developments in our understanding of the causes and the treatment of pemphigus will be reviewed. The goal will be to identify are as of research opportunity that will most effectively promote our further understanding of the causes and the treatments of pemphigus, and to cross-hybridize ideas on how to reach these goals among interested researchers. The conference will be organized around two major themes, each of one day's duration: 1) Advances in our understanding of the pathogenesis of pemphigus, and 2) advances in the treatment of this disease. Two workshops are planned to establish consensus among workers in the field on the diagnostic criteria for pemphigus and on the parameters used to evaluate the extent, activity, severity and response to therapy of this disease. There will be a poster session for advances that cannot be presented orally at the meeting. The conference is sponsored by two leading national lay organizations- one interested in pemphigus (International Pemphigus Foundation) the other more generally interested in autoimmune diseases (American Autoimmune Related Diseases Association. We expect it will attract 100-150 scientists and clinicians dedicated to investigate and treating pemphigus.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHASE II RANDOMIZED TRIAL OF IVIG WITH OR WITHOUT CYCLOPHOSPHAMIDE IN PEMPHIGUS
-
批准号:7211231
-
项目类别:
-
资助金额:$33.11万
-
财政年份:2007
-
负责人:JEAN-CLAUDE BYSTRYN
-
依托单位:
SERUM CYT-MAA AS AN EARLY MARKER OF RESPONSE TO THERAPY IN RESECTED MELANOMA
-
批准号:7314784
-
项目类别:
-
资助金额:$27.64万
-
财政年份:2007
-
负责人:JEAN-CLAUDE BYSTRYN
-
依托单位:
PHASE II RANDOMIZED TRIAL OF IVIG WITH OR WITHOUT CYCLOPHOSPHAMIDE IN PEMPHIGUS
-
批准号:7460522
-
项目类别:
-
资助金额:$33.11万
-
财政年份:2007
-
负责人:JEAN-CLAUDE BYSTRYN
-
依托单位:
Polypeptide Vaccine In IL-2 Liposomes For Prostate Ca
-
批准号:6438296
-
项目类别:
-
资助金额:$37.47万
-
财政年份:2002
-
负责人:JEAN-CLAUDE BYSTRYN
-
依托单位:
POLYVALENT VACCINE IN IL-2+GM-CSF LIPOSOMES FOR MELANOMA
-
批准号:6522757
-
项目类别:
-
资助金额:$34.96万
-
财政年份:2001
-
负责人:JEAN-CLAUDE BYSTRYN
-
依托单位:
POLYVALENT VACCINE IN IL-2+GM-CSF LIPOSOMES FOR MELANOMA
-
批准号:6651998
-
项目类别:
-
资助金额:$35.07万
-
财政年份:2001
-
负责人:JEAN-CLAUDE BYSTRYN
-
依托单位:
POLYVALENT VACCINE IN IL-2+GM-CSF LIPOSOMES FOR MELANOMA
-
批准号:6383569
-
项目类别:
-
资助金额:$34.86万
-
财政年份:2001
-
负责人:JEAN-CLAUDE BYSTRYN
-
依托单位:
PEMPHIGUS AS A MODEL ORGAN-SPECIFIC AUTOIMMUNE DISEASE
-
批准号:6323916
-
项目类别:
-
资助金额:$4.0万
-
财政年份:2001
-
负责人:JEAN-CLAUDE BYSTRYN
-
依托单位:
PEPTIDE SPECIFIC CD8 T CELLS AS MARKER OF VACCINE ACTION
-
批准号:2896622
-
项目类别:
-
资助金额:$16.5万
-
财政年份:1998
-
负责人:JEAN-CLAUDE BYSTRYN
-
依托单位:
PEPTIDE SPECIFIC CD8 T CELLS AS MARKER OF VACCINE ACTION
-
批准号:2682204
-
项目类别:
-
资助金额:$16.23万
-
财政年份:1998
-
负责人:JEAN-CLAUDE BYSTRYN
-
依托单位:
POTENTIATION OF CD8+ T CELL RESPONSE TO MELANOMA VACCINE
-
批准号:2748956
-
项目类别:
-
资助金额:$16.75万
-
财政年份:1997
-
负责人:JEAN-CLAUDE BYSTRYN
-
依托单位:
POTENTIATION OF CD8+ T CELL RESPONSE TO MELANOMA VACCINE
-
批准号:2384975
-
项目类别:
-
资助金额:$16.41万
-
财政年份:1997
-
负责人:JEAN-CLAUDE BYSTRYN
-
依托单位:
CLINICAL TRIAL OF AN IMPROVED MELANOMA VACCINE
-
批准号:2110107
-
项目类别:
-
资助金额:$16.97万
-
财政年份:1996
-
负责人:JEAN-CLAUDE BYSTRYN
-
依托单位:
CLINICAL TRIAL OF AN IMPROVED MELANOMA VACCINE
-
批准号:2376957
-
项目类别:
-
资助金额:$17.54万
-
财政年份:1996
-
负责人:JEAN-CLAUDE BYSTRYN
-
依托单位:
CLINICAL TRIAL OF MELANOMA VACCINE AND IL-2 IN LIPOSOME
-
批准号:2101550
-
项目类别:
-
资助金额:$14.88万
-
财政年份:1993
-
负责人:JEAN-CLAUDE BYSTRYN
-
依托单位:
IMMUNOLOGICAL EFFECTS OF MELANOMA VACCINE THERAPY
-
批准号:3202622
-
项目类别:
-
资助金额:$13.89万
-
财政年份:1993
-
负责人:JEAN-CLAUDE BYSTRYN
-
依托单位:
CLINICAL TRIAL OF MELANOMA VACCINE AND IL-2 IN LIPOSOME
-
批准号:2101549
-
项目类别:
-
资助金额:$14.0万
-
财政年份:1993
-
负责人:JEAN-CLAUDE BYSTRYN
-
依托单位:
IMMUNOLOGICAL EFFECTS OF MELANOMA VACCINE THERAPY
-
批准号:2099166
-
项目类别:
-
资助金额:$15.62万
-
财政年份:1993
-
负责人:JEAN-CLAUDE BYSTRYN
-
依托单位:
CLINICAL TRIAL OF MELANOMA VACCINE AND IL-2 IN LIPOSOME
-
批准号:3204280
-
项目类别:
-
资助金额:$13.09万
-
财政年份:1993
-
负责人:JEAN-CLAUDE BYSTRYN
-
依托单位:
IMMUNOLOGICAL EFFECTS OF MELANOMA VACCINE THERAPY
-
批准号:2099165
-
项目类别:
-
资助金额:$14.71万
-
财政年份:1993
-
负责人:JEAN-CLAUDE BYSTRYN
-
依托单位: